Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-03-03 00:00:00 ET · period of report 2024-12-31 · accession 0001649094-25-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | 2024-12-31 | PCVX | Wassil Jim | COO | G - Gift | $0.00 | -74.0K | 131.7K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | G | D | 74,000 | $0.00 | 131,695 | D | — | — | (F1) Represents a transfer of ownership of the Issuer's common stock to a charitable remainder trust of which the Reporting Person is not a trustee. This transaction is being reported late due to a delay in receiving the transaction information from the Reporting Person's broker and is being reported promptly upon discovery. |